The role of nitric oxide in the physiological regulation of Ca 2+ cycling

Current Opinion in Drug Discovery and Development

Volumn 6, Issue 5, 2003, Pages 658-666

  Khan, Shakil A ^a   Hare, Joshua M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Ca2+ channels; L type Ca2+ channel; Na+ Ca2+ exchanger; Nitric oxide; Ryanodine receptor; Sarcoplasmic reticulum Ca2+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL; CALCIUM ION; ION CHANNEL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; MUSCULOSKELETAL SYSTEM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TENSION; REVIEW; SARCOPLASMIC RETICULUM; SECOND MESSENGER; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM; HUMANS; MUSCLES; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SODIUM-CALCIUM EXCHANGER;

EID: 0142123156     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Hare JM: Role of nitric oxide in the regulation of cardiovascular performance. In: Shock, Sepsis, Organ Failure. Sixth Wiggers Bernard Conference 1997. Schlag G, Redl H (Eds), Springer Verlag, Berlin, Germany (1999):119-144.
2. 2+ homeostasis. Biochem Pharmacol (1998) 55(6):713-718.
3. Hare JM: Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol (2003) 35(7):719-729. A comprehensive review that gives an update on the role of NO in cardiac EC coupling; particular emphasis is given to NOS spatial confinement.
4. 2+ cycling and the force frequency response, and also supports the importance of NOS isoform spatial localization.
5. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER et al: Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 416(6878):337-339. This paper reports on the importance of spatial confinement of NO signaling by focusing on β-adrenergic responses in NOS1 and NOS3 knockout mice. Results from isolated myocyte experiments and in vivo studies are reported.
6. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA, Casadei B: Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res (2003) 92(5):e52-e59. A paper on NOS1 signaling, supporting the importance of NOS1 isoform spatial localization.
7. Feron O, Han X, Kelly RA: Muscarinic cholinergic signaling in cardiac myocytes: Dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sci (1999) 64(6-7):471-477.
8. Ziolo MT, Bers DM: The real estate of NOS signaling: Location, location, location. Circ Res (2003) 92(12):1279-1281. An editorial that emphasizes the importance of spatial co-localization of NOS isoforms with effector proteins.
9. Michel T, Feron O: Nitric oxide synthases: Which, where, how and why? J Clin Invest (1997) 100(9):2146-2152.
10. Wink DA, Mitchell JB: Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med (1998) 25(4-5):434-456.
11. Bates TE, Loesch A, Burnstock G, Clark JB: Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Comm (1996) 218(1):40-44.
12. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, de Groat WC, Peterson J: Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA (2001) 98(24):14126-14131.
13. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell (1994) 78(6):931-936.
14. 2+ cycling.
15. Schuh K, Uldrijan S, Telkamp M, Rothlein N, Neyses L: The plasmamembrane calmodulin-dependent calcium pump: A major regulator of nitric oxide synthase I. J Cell Biol (2001) 155(2):201-205.
16. 2+ cycling.
17. 2+ current to nitric oxide in frog ventricular myocytes. J Physiol (2001) 534(Pt 1):109-121.
18. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, Fischmeister R: Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest (1995) 95(2):794-802.
19. K,ACh in rat cardiac myocytes. J Physiol (2002) 540(Pt 2):411-424.
20. Gallo MP, Malan D, Bedendi I, Biasin C, Alloatti G, Levi RC: Regulation of cardiac calcium current by NO and cGMP-modulating agents. Pflug Arch Eur J Physiol (2001) 441(5):621-628.
21. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res (1997) 81(5):742-752.
22. Campbell DL, Stamler JS, Strauss HC: Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol (1996) 198(4):277-293.
23. Paolocci N, Ekelund UEG, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA, Hare JM: cGMP-independent inotropic effect of nitric oxide and peroxynitirite donors: Potential role for nitrosylation. Am J Physiol - Heart Circulat Physiol (2000) 279(4):H1982-H1988.
24. 2+ current elicited by withdrawal of acetylcholine in cat atrial myocytes. J Gen Physiol (1998) 111(1):113-125.
25. 3-Adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J Clin Invest (2000) 106(5):697-703.
26. Gyurko R, Fishman MC, Huang PL: Enhanced systolic contractility and preserved diastolic relaxation in mice deficient in endothelial nitric oxide synthase. In: The Biology of Nitric Oxide Part 6. Moncada S, Toda N, Maeda H, Higgs EA (Eds), Portland Press Ltd, London, UK (1998):24.
27. Ce-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA (1998) 95(11):6510-6515.
28. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R: Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med (1999) 5(3):331-334.
29. Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J: Inotropic response to β-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol (2001) 532(Pt 1):195-204.
30. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase. J Physiol (2000) 528(Pt 2):279-289.
31. 3-adrenoreceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 102(7):1377-1384.
32. Eu JP, Xu L, Stamler JS, Meissner G: Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol (1999) 57(10):1079-1084. An excellent review on RyR regulation by NO, covering the literature on skeletal and cardiac muscles.
33. 2+ release channel from oxidation induced activation. J Biol Chem (1997) 272(41):25462-25467.
34. Ziolo MT, Katoh H, Bers DM: Expression of inducible nitric oxide synthase depresses β-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation (2001) 104(24):2961-2966.
35. Xu L, Eu JP, Meissner G, Stamler JS: Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science (1998) 279(5348):234-237. A seminal report demonstrating that S-nitrosylation reversibly activates the cardiac RyR, whereas oxidation irreversibly activates the RyR.
36. 2+-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res (2002) 90(10):1114-1121.
37. Zahradnikova A, Minarovic I, Venema RC, Meszaros LG: Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium (1997) 22(6):447-454.
38. Sun J, Xin C, Eu JP, Stamler JS, Meissner G: Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA (2001) 98(20):11158-11162. This paper identifies the thiol that could be the primary site for activation of the RyR.
39. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS: A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature (2001) 410(6827):490-494.
40. Ganong W: Review of Medical Physiology. 21st Edition. Foltin J, Matragrano J, Ransom J, Davis K (Eds), Lange Medical Books, New York, NY, USA (2003).
41. Zhou L, Bumett AL, Huang PL, Becker LC, Kuppusamy P, Kass DA, Kevin Donahue J, Proud D, Sham JS, Dawson TM, Xu KY: Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. Biochem Biophys Res Commun (2002) 294(5):1030-1035.
42. 2+ ATPase activity by hypochlorous acid: Reversal by dfthiothreitol. Can J Physiol Pharmacol (1991) 69(11):1677-1685.
43. Stojanovic MO, Ziolo MT, Wahler GM, Wolska BM: Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am J Physiol - Cell Physiol (2001) 281 (1):C342-C349.
44. 2+ exchange. Circ Res (2002) 90(9):988-995.
45. Stamler JS, Meissner G: Physiology of nitric oxide in skeletal muscle. Physiol Rev (2001) 81 (1):209-237. A comprehensive review of NO physiology in skeletal muscle. Interesting information on the controversies regarding NO signaling is provided, including research from the authors' laboratory.
46. Wakayama Y, Inoue M, Murahashi M, Shibuya S, Jimi T, Kojima H, Oniki H: Ultrastructural localization of α1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin. Acta Neuropathol (1997) 94(5):455-464.
47. Gossrau R: Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle. Acta Histochem (1998) 100(1):99-112.
48. Kobzik L, Reid MB, Bredt DS, Stamler JS: Nitric oxide in skeletal muscle. Nature (1994) 372(6506):546-548.
49. Katsuki S, Arnold W, Mittal C, Murad F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res (1977) 3(1):23-35.
50. 2 sensor and NO signaling functions. Cell (2000) 102(4):499-509. This paper confirms that the effects of NO are dependent on environmental stimuli (in particular the redox state).
51. Meszaros LG, Minarovic I, Zahradnikova A: Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett (1996) 380(1-2):49-52.
52. 2+-ATPase in low-frequency stimulated rabbit muscle. FEBS Lett (1998) 422(3):381-384.
53. 2+-ATPase in skeletal muscle. Biochem J (1999) 340(Pt 3):657-669.
54. 2+-ATPase by nitric oxide. FEBS Lett (1998) 440(1-2):218-222.
55. Andrews KL, Triggle CR, Ellis A: NO and the vasculature: Where does it come from and what does it do? Heart Failure Rev (2002) 7(4):423-445.
56. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med (1993) 329(27):2002-2012.
57. Christopherson KS, Bredt DS: Nitric oxide in excitable tissues: Physiological roles and disease. J Clin Invest (1997) 100(10):2424-2429.
58. Lincoln TM, Cornwell TL: Intracellular cyclic GMP receptor proteins. FASEB J (1993) 7(2):328-338.
59. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium (1994) 15(2):122-131.
60. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (1994) 368(6474):850-853.
61. Hirata M, Kohse KP, Chang CH, Ikebe T, Murad F: Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem (1990) 265(3):1268-1273.
62. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J Biol Chem (1988) 263(17):8058-8065.
63. 2+ exchange in vascular smooth muscle cells in primary culture. J Biol Chem (1991) 266(19):12337-12341.
64. 2+ influx. Circ Res (1999) 84(2):210-219.
65. 2+ uptake activity can account for the reduced response to NO, but not sodium nitroprusside, in hypercholesterolemic rabbit aorta. Circulation (2001) 104(9):1040-1045.
66. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U: Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation (2003) 107(24):3081-3087.
67. Walia M, Samson SE, Schmidt T, Best K, Whittington M, Kwan CY, Grover AK: Peroxynitrite and nitric oxide differ in their effects on pig coronary artery smooth muscle. Am J Physiol - Cell Physiol (2003) 284(3):C649-C657.
68. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA (1994) 91(16):7583-7587.
69. Esplugues JV: NO as a signalling molecule in the nervous system. Br J Pharmacol (2002) 135(5):1079-1095.
70. Murphy S: Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia (2000) 29(1):1-13.
71. Kim SJ, Song SK, Kim J: Inhibitory effect of nitric oxide on voltage-dependent calcium currents in rat dorsal root ganglion cells. Biochem Biophys Res Commun (2000) 271(2):509-514.
72. Kim WK, Choi YB, Rayudu PV, Das P, Asaad W, Arnelle DR, Stamler JS, Lipton SA: Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO. Neuron (1999) 24(2):461-469.
73. Khaldi A, Chiueh CC, Bullock MR, Woodward JJ: The significance of nitric oxide production in the brain after injury. Ann NY Acad Sci (2002) 962:53-59.
74. Chiueh CC: Neuroprotective properties of nitric oxide. Ann NY Acad Sci (1999) 890:301-311.
75. Mohanakumar KP, Thomas B, Sharma SM, Muralikrishnan D, Chowdhury R, Chiueh CC: Nitric oxide: An antioxidant and neuroprotector. Ann NY Acad Sci (2002) 962:389-401.
76. 2+ mobilization by hypoxia-induced NO generation in rat brain striatal slices and human astrocytoma U-373 MG cells and its involvement in tissue damage. Eur J Neurosci (2003) 17(4):692-700.
77. Hom TF, Wolf G, Duffy S, Weiss S, Keilhoff G, MacVicar BA: Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons. FASEB J (2002) 16(12):1611-1622.
78. Boje KM, Arora PK: Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res (1992) 587(2):250-256.